Collectively, these findings suggest that ZBP1 deficiency is linked to a regulatory shift from proliferation–invasion pathways towards immune–apoptotic regulons, thereby offering a plausible mechanistic explanation for its tumor-suppressive function. Here, ZBP1 is linked to neoplasm.